| Product Code: ETC9614781 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan Benign Prostatic Hyperplasia Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan Benign Prostatic Hyperplasia Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan Benign Prostatic Hyperplasia Market - Industry Life Cycle |
3.4 Taiwan Benign Prostatic Hyperplasia Market - Porter's Five Forces |
3.5 Taiwan Benign Prostatic Hyperplasia Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Taiwan Benign Prostatic Hyperplasia Market Revenues & Volume Share, By Distribution Channels, 2021 & 2031F |
4 Taiwan Benign Prostatic Hyperplasia Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of benign prostatic hyperplasia (BPH) in the aging population in Taiwan |
4.2.2 Growing awareness about BPH and the availability of treatment options |
4.2.3 Technological advancements in BPH treatment leading to improved outcomes |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval of BPH treatment options in Taiwan |
4.3.2 Limited reimbursement policies for BPH treatments |
4.3.3 High cost associated with BPH treatment options impacting affordability for patients |
5 Taiwan Benign Prostatic Hyperplasia Market Trends |
6 Taiwan Benign Prostatic Hyperplasia Market, By Types |
6.1 Taiwan Benign Prostatic Hyperplasia Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Taiwan Benign Prostatic Hyperplasia Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 Taiwan Benign Prostatic Hyperplasia Market Revenues & Volume, By Alpha-Blockers, 2021- 2031F |
6.1.4 Taiwan Benign Prostatic Hyperplasia Market Revenues & Volume, By 5- Alpha-Reductase Inhibitors (5-Aris), 2021- 2031F |
6.1.5 Taiwan Benign Prostatic Hyperplasia Market Revenues & Volume, By Alpha-Adrenergic Blockers, 2021- 2031F |
6.1.6 Taiwan Benign Prostatic Hyperplasia Market Revenues & Volume, By Phosphodiesterase-5 Enzyme Inhibitors, 2021- 2031F |
6.1.7 Taiwan Benign Prostatic Hyperplasia Market Revenues & Volume, By Other Drug Types, 2021- 2031F |
6.2 Taiwan Benign Prostatic Hyperplasia Market, By Distribution Channels |
6.2.1 Overview and Analysis |
6.2.2 Taiwan Benign Prostatic Hyperplasia Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.2.3 Taiwan Benign Prostatic Hyperplasia Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.2.4 Taiwan Benign Prostatic Hyperplasia Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 Taiwan Benign Prostatic Hyperplasia Market Import-Export Trade Statistics |
7.1 Taiwan Benign Prostatic Hyperplasia Market Export to Major Countries |
7.2 Taiwan Benign Prostatic Hyperplasia Market Imports from Major Countries |
8 Taiwan Benign Prostatic Hyperplasia Market Key Performance Indicators |
8.1 Average age of diagnosis for BPH patients in Taiwan |
8.2 Adoption rate of minimally invasive BPH treatment procedures |
8.3 Number of healthcare facilities offering specialized BPH treatment services |
9 Taiwan Benign Prostatic Hyperplasia Market - Opportunity Assessment |
9.1 Taiwan Benign Prostatic Hyperplasia Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Taiwan Benign Prostatic Hyperplasia Market Opportunity Assessment, By Distribution Channels, 2021 & 2031F |
10 Taiwan Benign Prostatic Hyperplasia Market - Competitive Landscape |
10.1 Taiwan Benign Prostatic Hyperplasia Market Revenue Share, By Companies, 2024 |
10.2 Taiwan Benign Prostatic Hyperplasia Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here